The ester-containing prodrug NT-0796 enhances delivery of the NLRP3 inflammasome inhibitor NDT-19795 to monocytic cells expressing carboxylesterase-1
John R. Doedens, Christopher A. Gabel(University of North Carolina at Chapel Hill), Nicholas Clarke, David Harrison(University of Notre Dame), Alan P. Watt(Chelmsford and Essex Hospital), Mark G. Bock, Christine Diamond(University of North Carolina at Chapel Hill)
Cited by 5
Related Papers
Ubiquitin Ligase Substrate Identification through Quantitative Proteomics at Both the Protein and Peptide Levels
|Journal of Biological Chemistry|2011|85
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
|European Journal of Pharmacology|2014|54
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796
|Journal of Pharmacology and Experimental Therapeutics|2024|51
Myocardial Hypertrophy Resulting from Low Dosage Isoproterenol Administration in Rats
|Experimental Biology and Medicine|1971|49